Introducing BioFlash®, a rapid diagnostic system for the ultra-sensitive detection of pathogens.

Technology Overview:

The BioFlash® system is based on the CANARY® (Cellular Analysis and Notification of Antigen Risks and Yields) technology, a revolutionary diagnostic technology developed by the scientists at Massachusetts Institute of Technology and published in Science.

CANARY® incorporates pathogen-specific antibodies expressed on a biosensor surface that, in the presence of a pathogen (virus, bacteria or toxin), trigger an intracellular calcium release that in-turn activates bioluminescent proteins to generate the emission of light.

BioFlash® delivers extremely rapid detection of pathogens at previously unseen levels of sensitivity and specificity. Accurate results can be obtained in less than 3 minutes by non-expert users.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

For a more detailed description of the product and it's technology, please contact PathSensors directly.